Five cases of new-onset pemphigus following vaccinations against coronavirus disease 2019.

Pemphigus is a group of blistering disorders characterized by the formation of intraepithelial blisters in skin and mucous membranes induced by the binding of circulating autoantibodies to intercellular adhesion molecules. The pathogenesis is complex and not fully understood; however, genetic predisposition and various triggers are widely accepted as key factors in pemphigus development. A few cases of new-onset pemphigus following coronavirus disease 2019 (COVID-19) vaccination have already been published. The present paper reports a total of two cases of pemphigus foliaceous and three cases of pemphigus vulgaris that occurred following vaccinations against COVID-19, with anamnestic, clinical, and diagnostic data collection suggesting assumptions over a possible causal correlation.

© 2022 The Authors. The Journal of Dermatology published by John Wiley & Sons Australia, Ltd on behalf of Japanese Dermatological Association.

Overview publication

TitleFive cases of new-onset pemphigus following vaccinations against coronavirus disease 2019.
Date2023-02-01
Issue nameThe Journal of dermatology
Issue numberv50.2:229-233
DOI10.1111/1346-8138.16554
PubMed35975548
AuthorsCorrá A, Barei F, Genovese G, Zussino M, Spigariolo CB, Mariotti EB, Quintarelli L, Verdelli A, Caproni M & Marzano AV
KeywordsCOVID-19, mRNA BNT162b2, mRNA-1273, pemphigus foliaceus, pemphigus vulgaris
Read Read publication